INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 220 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $21 | -77.4% | 47,902 | -19.9% | 0.00% | -83.3% |
Q4 2022 | $93 | -100.0% | 59,812 | -54.3% | 0.01% | -42.9% |
Q3 2022 | $226,000 | +52.7% | 130,829 | +53.0% | 0.02% | +61.5% |
Q2 2022 | $148,000 | -31.8% | 85,504 | +181.8% | 0.01% | -31.6% |
Q3 2021 | $217,000 | +102.8% | 30,338 | +163.6% | 0.02% | +137.5% |
Q1 2021 | $107,000 | -85.6% | 11,511 | -86.3% | 0.01% | -90.0% |
Q4 2020 | $744,000 | -5.2% | 84,012 | +24.1% | 0.08% | -40.7% |
Q3 2020 | $785,000 | +792.0% | 67,686 | +155.0% | 0.14% | +1400.0% |
Q4 2019 | $88,000 | +183.9% | 26,543 | +75.0% | 0.01% | +350.0% |
Q3 2019 | $31,000 | -55.7% | 15,164 | -36.4% | 0.00% | -50.0% |
Q2 2019 | $70,000 | -44.0% | 23,850 | -23.8% | 0.00% | -42.9% |
Q4 2018 | $125,000 | -36.2% | 31,318 | -24.8% | 0.01% | -36.4% |
Q1 2018 | $196,000 | +83.2% | 41,629 | +60.2% | 0.01% | +83.3% |
Q4 2017 | $107,000 | -64.7% | 25,990 | -45.6% | 0.01% | -60.0% |
Q3 2017 | $303,000 | – | 47,803 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |